Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9241726rdf:typepubmed:Citationlld:pubmed
pubmed-article:9241726lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C0004461lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C1176472lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:9241726lifeskim:mentionsumls-concept:C0205374lld:lifeskim
pubmed-article:9241726pubmed:issue1lld:pubmed
pubmed-article:9241726pubmed:dateCreated1997-10-1lld:pubmed
pubmed-article:9241726pubmed:abstractTextTwo experiments were carried out to evaluate the relative contributions of thalamocortical and raphe-cortical fibers to the transient somatotopically organized pattern of serotonin (5-HT) immunoreactivity that appears in the primary somatosensory cortex (SI) of rats during the first 2 weeks of life. In the first experiment, the specific 5-HT uptake inhibitors, fluoxetine and paroxetine, were administered systemically, animals were killed 3, 6, or 12 h later, and cortices evaluated for 5-HT immunoreactivity. Fluoxetine treatment had no appreciable effect on the density of 5-HT immunoreactivity in the cortex. Paroxetine treatment caused a reduction in 5-HT immunoreactivity which was maximal 6 h after administration. Examination of the cortices of these animals revealed a loss of very fine dust-like 5-HT immunoreactivity, but a vibrissae-related pattern remained visible in thicker fibers. In a second experiment, raphe-cortical fibers were destroyed by systemic administration of 5,7-dihydroxytryptamine on the day of birth. Six days after this manipulation, 5-HT was applied directly to the cortex in vivo and the animals were then killed and cortices processed to demonstrate 5-HT immunoreactivity. The cortices of these rats revealed a fine dust-like immunoreactivity organized in a somatotopic pattern, but only very few 5-HT-positive axons. The results of these experiments suggest that both raphe-cortical axons and thalamocortical fibers contribute to the patterned 5-HT immunoreactivity observed in SI of perinatal rats.lld:pubmed
pubmed-article:9241726pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:languageenglld:pubmed
pubmed-article:9241726pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:citationSubsetIMlld:pubmed
pubmed-article:9241726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9241726pubmed:statusMEDLINElld:pubmed
pubmed-article:9241726pubmed:issn0899-0220lld:pubmed
pubmed-article:9241726pubmed:authorpubmed-author:RhoadesR WRWlld:pubmed
pubmed-article:9241726pubmed:authorpubmed-author:ChiaiaN LNLlld:pubmed
pubmed-article:9241726pubmed:authorpubmed-author:Bennett-Clark...lld:pubmed
pubmed-article:9241726pubmed:issnTypePrintlld:pubmed
pubmed-article:9241726pubmed:volume14lld:pubmed
pubmed-article:9241726pubmed:ownerNLMlld:pubmed
pubmed-article:9241726pubmed:authorsCompleteYlld:pubmed
pubmed-article:9241726pubmed:pagination27-33lld:pubmed
pubmed-article:9241726pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:meshHeadingpubmed-meshheading:9241726-...lld:pubmed
pubmed-article:9241726pubmed:year1997lld:pubmed
pubmed-article:9241726pubmed:articleTitleContributions of raphe-cortical and thalamocortical axons to the transient somatotopic pattern of serotonin immunoreactivity in rat cortex.lld:pubmed
pubmed-article:9241726pubmed:affiliationDepartment of Anatomy and Neurobiology, Medical College of Ohio, Toledo 43699, USA.lld:pubmed
pubmed-article:9241726pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9241726pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9241726lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9241726lld:pubmed